SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-23-015818
Filing Date
2023-05-04
Accepted
2023-05-04 17:10:06
Documents
4
Effectiveness Date
2023-05-04

Document Format Files

Seq Description Document Type Size
1 S-8 avtx-formsx82023eipesppeve.htm S-8 62564
2 EX-FILING FEES ex-107sx8filingfeetable.htm EX-FILING FEES 19052
3 EX-5.1 ex-51sx8wyrickopinionconse.htm EX-5.1 7248
4 EX-23.1 ex-231sx8eyconsenteipesppe.htm EX-23.1 2393
  Complete submission text file 0001628280-23-015818.txt   92353
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271655 | Film No.: 23889916
SIC: 2834 Pharmaceutical Preparations